Clearside Biomedical Inc (CLSD)
1.06
+0.01
(+0.95%)
USD |
NASDAQ |
Nov 21, 14:05
Clearside Biomedical Price: 1.06 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 1.04 | 1.07 | 1.03 | 1.05 | 169511.0 |
Nov 19, 2024 | 1.03 | 1.06 | 1.01 | 1.03 | 349650.0 |
Nov 18, 2024 | 0.99 | 1.04 | 0.99 | 1.02 | 346948.0 |
Nov 15, 2024 | 1.06 | 1.066 | 0.9757 | 0.99 | 435642.0 |
Nov 14, 2024 | 1.07 | 1.096 | 1.04 | 1.05 | 148267.0 |
Nov 13, 2024 | 1.08 | 1.15 | 1.06 | 1.08 | 278805.0 |
Nov 12, 2024 | 1.10 | 1.16 | 1.08 | 1.11 | 254723.0 |
Nov 11, 2024 | 1.13 | 1.15 | 1.06 | 1.09 | 340764.0 |
Nov 08, 2024 | 1.16 | 1.16 | 1.11 | 1.14 | 294946.0 |
Nov 07, 2024 | 1.09 | 1.13 | 1.08 | 1.11 | 254935.0 |
Nov 06, 2024 | 1.07 | 1.110 | 1.06 | 1.08 | 215279.0 |
Nov 05, 2024 | 1.06 | 1.09 | 1.05 | 1.07 | 273901.0 |
Nov 04, 2024 | 1.01 | 1.045 | 1.004 | 1.03 | 249958.0 |
Nov 01, 2024 | 0.9988 | 1.02 | 0.99 | 1.01 | 299761.0 |
Oct 31, 2024 | 1.04 | 1.045 | 0.99 | 1.02 | 558924.0 |
Oct 30, 2024 | 1.04 | 1.08 | 1.03 | 1.04 | 252866.0 |
Oct 29, 2024 | 1.10 | 1.106 | 1.04 | 1.05 | 333931.0 |
Oct 28, 2024 | 1.10 | 1.126 | 1.07 | 1.10 | 272893.0 |
Oct 25, 2024 | 1.11 | 1.12 | 1.06 | 1.10 | 390032.0 |
Oct 24, 2024 | 1.14 | 1.17 | 1.07 | 1.10 | 528419.0 |
Oct 23, 2024 | 1.20 | 1.20 | 1.11 | 1.135 | 371586.0 |
Oct 22, 2024 | 1.32 | 1.32 | 1.16 | 1.185 | 531632.0 |
Oct 21, 2024 | 1.14 | 1.32 | 1.14 | 1.32 | 2.221M |
Oct 18, 2024 | 1.11 | 1.168 | 1.11 | 1.15 | 252045.0 |
Oct 17, 2024 | 1.11 | 1.166 | 1.096 | 1.15 | 472582.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.68
Minimum
Oct 26 2023
7.20
Maximum
Aug 27 2021
2.032
Average
1.51
Median
Feb 22 2022
Price Benchmarks
Perspective Therapeutics Inc | 3.105 |
Viking Therapeutics Inc | 53.14 |
Atara Biotherapeutics Inc | 10.24 |
Corvus Pharmaceuticals Inc | 8.90 |
Crinetics Pharmaceuticals Inc | 57.53 |
Price Related Metrics
PS Ratio | 9.693 |
Earnings Yield | -42.45% |
Market Cap | 80.39M |